Literature DB >> 6284783

Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.

R M Jordan, A Ramos-Gabatin, J W Kendall, D Gaudette, R C Walls.   

Abstract

We have studied a 57-yr-old woman with cyclic Cushing's syndrome of apparent pituitary origin who had a predominant cycle of 2-6 days. The patient also demonstrated an abnormal circadian rhythm, with afternoon peaks of plasma ACTH and plasma cortisol. In addition to these abnormal biorhythms, Fourier analysis showed what appeared to be a separate 35-day cycle. After 35 days of consecutive urinary free cortisol measurement, the patient was given cyproheptadine. During therapy with this agent, the urinary free cortisol levels fell dramatically, but cyclic secretion continued, albeit with a diminished amplitude. During general anesthesia for a bilateral adrenalectomy, there was a striking increase in the plasma ACTH level, and the ACTH concentration remained high in both the immediate and late postoperative periods. These observations indicated that stress could overcome cyclic ACTH secretion and that cortisol exerted feedback suppression on ACTH secretion. Although this is the predictable response for classic pituitary-dependent Cushing's syndrome, it is of interest in cyclic Cushing's syndrome, since previous studies of this entity have implied that cortisol secretion is independent of stimulation or feedback.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284783     DOI: 10.1210/jcem-55-3-531

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Cyclical Cushing's disease and its successful control under sodium valproate.

Authors:  A Beckers; A Stevenaert; G Pirens; P Flandroy; J Sulon; G Hennen
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Cushing's syndrome with intermittent ectopic ACTH production.

Authors:  A van Coevorden; E Laurent; F Rickaert; O van Reeth; E Van Cauter; J Mockel
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

3.  Cyclical Cushing's disease: report of a case cured by conventional cobaltotherapy.

Authors:  M L De Feo; L Bonfanti; S Romano; S Fusi; G Giusti; G Messeri; G Forti
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

4.  Cyclic Cushing's disease with paradoxical response to dexamethasone.

Authors:  S Checchi; L Brilli; E Guarino; C Ciuoli; G Di Cairano; P Mazzucato; F Pacini
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 5.  Cyclic Cushing's syndrome: an overview.

Authors:  Franco Mantero; Carla M Scaroni; Nora M E Albiger
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Cyproheptadine treatment in Cushing's disease.

Authors:  R Tanakol; F Alagöl; H Azizlerli; O Sandalci; T Terzioğlu; F Berker
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

7.  Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.

Authors:  S Cannavò; L Li Calzi; A Aragona; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

8.  Persistence of a circadian rhythmicity of glucocorticoid secretion in a patient with Cushing's syndrome: study before and after unilateral adrenalectomy.

Authors:  B Ambrosi; E Riva; G Faglia
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

9.  Five cases of cyclical Cushing's syndrome.

Authors:  A B Atkinson; A L Kennedy; D J Carson; D R Hadden; J A Weaver; B Sheridan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23

10.  A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing's syndrome.

Authors:  Adriana Albani; Christina M Berr; Felix Beuschlein; Marcus Treitl; Klaus Hallfeldt; Jürgen Honegger; Günter Schnauder; Martin Reincke
Journal:  BMC Endocr Disord       Date:  2019-10-22       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.